Transforming growth factor-β and ciliary neurotrophic factor synergistically induce vasoactive intestinal peptide gene expression through the cooperation of Smad, STAT, and AP-1 sites

被引:29
作者
Pitts, RL [1 ]
Wang, SB [1 ]
Jones, EA [1 ]
Symes, AJ [1 ]
机构
[1] Uniformed Serv Univ Hlth Sci, Dept Pharmacol, Bethesda, MD 20814 USA
关键词
D O I
10.1074/jbc.M011759200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The cytokine ciliary neurotrophic factor (CNTF) and transforming growth factor-beta (TGF-beta) both induce transcription of the vasoactive intestinal peptide (VIP) gene through a 180-base pair cytokine response element (CyRE) in the VIP promoter. While CNTF induces STAT and AP-1 proteins to bind to cognate sites in the VIIP CS;RE, the mechanism through which TGF-beta acts to induce VIP gene transcription is not known. Here we show that Smad3 and Smad4 proteins can bind to two distinct sites within the VIP CyRE. These sites are absolutely required for the induction of VIP CyRE transcription, by TGF-beta. TGF-beta induces endogenous Smad;containing complexes to bind to these sites in human neuroblastoma cells. CNTF and TGF-beta synergize to induce VIP mRNA expression and transcription through the VIP CyRE. This synergy is dependent on the Smad, STAT, and AP-1 sites, suggesting that these two independent cytokine pathways synergize through the cooperation of pathway-specific transcription factors binding to distinct sites within the VIP CyRE.
引用
收藏
页码:19966 / 19973
页数:8
相关论文
共 50 条
[21]   Combined transforming growth factor-β1 and 3 fibroblast stimulation modifies the extracellular matrix gene expression through Smad independant signaling [J].
Ng, Yoke Leng ;
Lloyd, Frances ;
Appelbee, Amber ;
Klopcic, Borut ;
Lawrance, Ian C. .
GASTROENTEROLOGY, 2007, 132 (04) :A568-A568
[22]   Patterns and sites of tumor necrosis factor-α and transforming growth factor-β1 expression in human renal allograft biopsies [J].
Park, KK ;
Han, SM ;
Jegal, MY ;
Jeong, HS ;
Lee, JG ;
Kim, HC .
TRANSPLANTATION PROCEEDINGS, 2003, 35 (01) :249-250
[23]   A far-upstream AP-1/Smad binding box regulates human NOX4 promoter activation by transforming growth factor-β [J].
Bai, Guangxing ;
Hock, Thomas D. ;
Logsdon, Naomi ;
Zhou, Yong ;
Thannickal, Victor J. .
GENE, 2014, 540 (01) :62-67
[24]   Regulation of transforming growth factor-β signaling by protein inhibitor of activated STAT, PIASy through Smad3 [J].
Imoto, S ;
Sugiyama, K ;
Muromoto, R ;
Sato, N ;
Yamamoto, T ;
Matsuda, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (36) :34253-34258
[25]   A short region containing an AP-1 binding site is essential for transforming growth factor-β-induced c-jun gene expression in osteoblastic cells [J].
Hata, S ;
Shimizu, T ;
Fujimoto, M .
IUBMB LIFE, 2000, 49 (03) :229-234
[26]   Effects of exogenous transforming growth factor-β1 on early expression of Smad3 and Smad7 [J].
Keshu, Guo Qionya Xu .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 :397-397
[27]   Role of AP-1 complex in angiotensin II-mediated transforming growth factor-β expression and growth of smooth muscle cells:: Using decoy approach against AP-1 binding site [J].
Morishita, R ;
Gibbons, GH ;
Horiuchi, M ;
Kaneda, Y ;
Ogihara, T ;
Dzau, VJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 243 (02) :361-367
[28]   E1A inhibits transforming growth factor-β signaling through binding to Smad proteins [J].
Nishihara, A ;
Hanai, J ;
Imamura, T ;
Miyazono, K ;
Kawabata, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (40) :28716-28723
[29]   C/EBP-RELATED SITES IN ADDITION TO A STAT SITE ARE NECESSARY FOR CILIARY NEUROTROPHIC FACTOR-LEUKEMIA FACTOR-DEPENDENT TRANSCRIPTIONAL ACTIVATION BY THE VASOACTIVE-INTESTINAL-PEPTIDE CYTOKINE RESPONSE ELEMENT [J].
SYMES, AJ ;
RAJAN, P ;
CORPUS, L ;
FINK, JS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (14) :8068-8075
[30]   Ciliary neurotrophic factor (CNTF) induction of vasoactive intestinal peptide (VIP) expression in the corneal endothelium (CE) in preserved donor human corneas [J].
Koh, SWM ;
Liu, XH ;
Symes, AJ ;
Waschek, JA .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 :U306-U306